TGFB1 and systemic sclerosis: Through the addition of TGFβ, a known fibrosis factor in SSc, it is possible to induce pathological responses in cells similar to those observed in vivo, therefore creating a SSc model that allows for the measurement of protein production, gene expression or drug response [177].